Abstract:Polyaspartoyl.l-arginine (PDR) is an inhibitor of platelet aggregation ex vivo but in vitro. This study attempts to elucidate the target cell of PDR action and its action mechanism. PDR (1.7-170 microg/ml) significantly inhibited platelet aggregation in vitro in the presence of rat aortic endothelial cells (RAEC), NO synthase inhibitor N-nitro-l-arginine methyl ester (l-NAME) inhibited this effect, but it was ineffective in the RAEC absence. Correspondingly, PDR increased NO level in the supernatants of the platelet reactants in RAEC presence, but failed to influence NO level in RAEC absence, and these effects of PDR were more potent than those of l-arginine. Furthermore, PDR markedly elevated the intracellular level of l-arginine, and it (17-170 microg/ml) also augmented l-citrulline level in RAEC, argininosuccinate lyase (ASL) inhibitor succinate enhanced its effect on l-citrulline but l-NAME weakened it. 170 microg/ml of PDR slightly increased the l-aspartate level in RAEC, and succinate enhanced this effect. However l-arginine, l-aspartate or the combination of l-arginine and l-aspartate failed to change levels of these amino acids. In addition, PDR (170 microg/ml) stimulated the expression of argininosuccinate synthetase (ASS) protein. In conclusion, the endothelial cell is direct target cell of PDR's action; PDR facilitates the entry of l-arginine by serving as a carrier of l-arginine into RAEC; it also supplies aspartic acid and stimulates ASS expression, and then enhances the intracellular citrulline-NO cycle, thus increases the availability of l-arginine and NO synthesis. Therefore the effect of PDR on platelet aggregation is primarily attributed to its stimulation of NO synthesis in endothelial cells; PDR may be a better cardiovascular protective agent than l-arginine.

Synthesis, Nano-Features, Ex Vivo Anti-Platelet Aggregation and in Vivo Antithrombotic Activities of Poly-Α,β-dl-aspartyl-l-arginine

Synthesis, Nanofeatures, in Vitro Thrombus Lysis Activity and in Vivo Thrombolytic Activity of Poly-Alpha,Beta-Aspartyl-L-Alanine

Inhibition of Platelet Aggregation by Polyaspartoyl L-Arginine and Its Mechanism

Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing l-Arg and l-Asp or l-Glu

Selective binding of cationic fibrinogen-mimicking chitosan nanoparticles to activated platelets and efficient drug release for antithrombotic therapy

Design, Synthesis and Evaluation of Nitric Oxide Releasing Derivatives of 3-N-butylphthalide As Antiplatelet and Antithrombotic Agents.

Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity.

The Potential Pathway of L-arginine·L-aspartate for Inhibition of Platelet Function

Design, Synthesis and Evaluation of Novel 2-Amino-3-(naphth-2-yl)propanoic Acid Derivatives As Potent Inhibitors of Platelet Aggregation

Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents

Synthesis and Biological Evaluation of N-Butylphthalide Derivatives As Anti-Platelet Aggregation Agents

Design and Characterization of Antithrombotic Nanoconjugate―m5k-BAD-L

Orally Delivered Rutin in Lipid-Based Nano-Formulation Exerts Strong Antithrombotic Effects by Protein Disulfide Isomerase Inhibition.

The effect of L-arginine L-aspartate on arterial thrombosis model and its mechanism

Inhibition of Arterial Thrombus Formation by Blocking Exposed Collagen Surface Using LWWNSYY-Poly(L-Glutamic Acid) Nanoconjugate

Novel Peptide Motifs Containing Asp-Glu-Gly Target P2Y12 and Thromboxane A2 Receptors to Inhibit Platelet Aggregation and Thrombus Formation

Design, Synthesis And Biological Evaluation Of Hydrogen Sulfide Releasing Derivatives Of 3-N-Butylphthalide As Potential Antiplatelet And Antithrombotic Agents

Synthesis and Antithrombotic Activity of Carbolinecarboxyl RGD Sequence.

Synthesis and Bioactivities of Nitronyl Nitroxide and RGD Containing Pseudopeptides

Polyaspartoyl·l-arginine Inhibits Platelet Aggregation Through Stimulation of NO Release from Endothelial Cells

Preparation and Characterization of a Novel Aspirin Derivative with Anti-Thrombotic and Gastric Mucosal Protection Properties